Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
This study is currently recruiting participants.
Verified July 2010
by Beijing Cancer Hospital
Study NCT01167049 Information provided by Beijing Cancer Hospital
First Received on July 21, 2010. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastric Cancer
Additional conditions recognized in this trial
Liver Neoplasms
Neoplasm Metastasis
Stomach Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Stomach Diseases
Interventions listed in this trial
CAPECITABINE
Additional drug interventions recognized in this trial
Fluorouracil
Paclitaxel
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Beijing Cancer Hospital
Roche Pharma AG
Back to top of Main Content
